Company News

bioMérieux, a world leader in in vitro diagnostics, announces the launch of GENE-UP^® BREWPRO™ Yeast Slurry (YS) - the first-of-its-kind diagnostic quality control PCR test designed to specifically detect contaminants in raw yeast materials and yeast propagations to ensure top quality fermentations. 

In recognition of National Food Safety Education Month, bioMérieux, a world leader in in vitro diagnostics, continues its long-standing collaboration with the food safety industry to provide a comprehensive suite of solutions and services for infant formula manufacturers and ingredient suppliers to minimize risk of Cronobacter spp, Salmonella and other microbiological hazards at every stage of the production process.

bioMérieux, a world leader in in vitro diagnostics, has announced the lease signing of a new, 32,000 sq. ft. state-of-the-art molecular innovation center at the Navy Yard in Philadelphia.

bioMérieux and JMI Laboratories (JMI) are announcing a six-year partnership to undertake collaborative projects evaluating the performance and increasing potential of rapid and innovative microbiology diagnostics as important tools in the battle against AMR.

bioMérieux, a world leader in in vitro diagnostics for 60 years, is pleased to announce the availability of GENE-UP^® PRO GENDER ID and GENE-UP^® PRO HOP LATENT VIROID (HLVd) quality control solutions.